Regulatory Publishing and Submissions

A Japan-based pharmaceutical manufacturer sought to enter the US market with multiple products but faced challenges in managing submission complexity, ensuring consistency across dossiers, and meeting stringent FDA timelines. Freyr partnered with the client to standardize publishing and submission processes, enabling efficient dossier preparation, timely submissions, and successful market entry.

A Japanese midsize global pharma and biotech company, having collaborated with Freyr for over three years, had sought Freyr's expertise for comprehensive submission publishing support in the US and Canada. Freyr had defined, implemented, and maintained best practices in publishing processes, ensuring 100% on-time submissions and achieving over 50% cost savings. This significantly boosted the company's process efficiency and compliance.

A US-based multinational company had faced multiple Regulatory challenges with eCTD submission compliance in the EAEU region. They had turned to Freyr for comprehensive consultation support. Freyr's meticulous approach resolved their compliance concerns, resulting in rapid turnaround times, zero errors, and enhanced Regulatory efficiency.

A global healthcare company required comprehensive Regulatory support for managing over 40+ submission operations for their gynecological products in China and Japan. They had turned to Freyr, who provided end-to-end submission services. Freyr efficiently managed the high volume of submissions, enhanced the company's operational efficiency, and ensured Regulatory compliance.

A Japanese pharmaceutical and biotechnology company with a long-standing relationship with Freyr sought to strengthen its global submission capabilities while ensuring regulatory compliance across multiple markets. Freyr provided comprehensive publishing, submission, and operational support, enabling the client to accelerate submissions, improve efficiency, and expand regulatory operations globally.

Delivering comprehensive DMF submission support, Regulatory publishing, submission management, and quality control services for a Drug Master File (DMF) application while ensuring compliance with US FDA requirements, eCTD publishing standards, Regulatory submission timelines, and global Regulatory Affairs best practices.

Providing comprehensive Regulatory Affairs support in China and Japan for post-approval changes, renewals, variations, supplemental CMC submissions, labeling safety activities, Regulatory publishing, and submission management, while ensuring compliance, quality, operational efficiency, and alignment with local Health Authority requirements.

Providing Regulatory Operations support, Publishing Services, Clinical Trial Support (CTS), data migration activities, and SOP development to accelerate Regulatory submissions across existing and new markets.

Managing the complete submission lifecycle, standardizing submission processes, and supporting a Japanese drug manufacturer's successful expansion into the United States while ensuring compliance with US Regulatory requirements.